The role of fibroblast growth factor receptor 4 (FGFR4) signaling in anti-EGFR resistance in colon cancer.

被引：0
|
作者：
Cho, Sang Hee
Kim, Jo-Heon
Hong, Chang-Soo
Sun, Eun-Gene
Ryu, Kyung-Hyun
Hwang, Jun Eul
Bae, Woo Kyun
Chung, Ik-Joo
Bang, Hyun-Jin
机构：
[1] Chonnam Natl Univ, Hwasun Hosp, Dept Hematol Oncol, Hwasun, South Korea
[2] Chonnam Natl Univ, Hwasun Hosp, Dept Pathol, Hwasuneup, South Korea
[3] Sookmyung Womens Univ, Dept Biol Sci, Seoul, South Korea
[4] Chonnam Natl Univ, Med Sch, Gwangju, South Korea
[5] Chonnam Natl Univ, Hwasun Hosp, Hwasun, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
基金：
新加坡国家研究基金会;
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4060
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Fibroblast growth factor 9 gene amplification can induce resistance to anti-EGFR therapy in colorectal cancer
    Mizukami, T.
    Togashi, Y.
    Banno, E.
    Terashima, M.
    De Velasco, M. A.
    Sakai, K.
    Hayashi, H.
    Fujita, Y.
    Tomida, S.
    Nakajima, T. Eguchi
    Boku, N.
    Ito, A.
    Nakagawa, K.
    Nishio, K.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S46 - S46
  • [32] Fibroblast growth factor receptor 4 gene (FGFR4) 388Arg allele predicts prolonged survival and platinum sensitivity in advanced ovarian cancer
    Marme, Frederik
    Hielscher, Thomas
    Hug, Sarah
    Bondong, Sandra
    Zeillinger, Robert
    Castillo-Tong, Dan Cacsire
    Sehouli, Jalid
    Braicu, Ioana
    Vergote, Ignace
    Isabella, Cadron
    Mahner, Sven
    Ferschke, Irmgard
    Rom, Joachim
    Sohn, Christof
    Schneeweiss, Andreas
    Altevogt, Peter
    INTERNATIONAL JOURNAL OF CANCER, 2012, 131 (04) : E586 - E591
  • [33] Fibroblast growth factor receptor 4 (FGFR4) variant p. Gly388Arg in Czech children carcinoma patients
    Valaskova, I.
    Drabova, K.
    Spesna, R.
    Gaillyova, R.
    Sterba, J.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 1899 - 1899
  • [34] Fibroblast growth factor receptor-4 (FGFR-4) as a novel therapeutic target for pancreatic cancer
    Ishiwata, Toshiyuki
    Yoshimura, Hisashi
    Matsuda, Yoko
    Ishiwata, Shunji
    CANCER RESEARCH, 2016, 76
  • [35] The fibroblast growth factor receptor 4 (FGFR4) Arg388 allele correlates with survival in head and neck squamous cell carcinoma
    Andrade, Valeria Cristina da Costa
    Parise, Orlando, Jr.
    Hors, Cora Pereira
    Martins, Poliana Cristina de Melo
    Silva, Alexandre Pacheco
    Garicochea, Bernardo
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2007, 82 (01) : 53 - 57
  • [36] Negative Regulation of FGFR (Fibroblast Growth Factor Receptor) Signaling
    Szybowska, Patrycja
    Kostas, Michal
    Wesche, Jorgen
    Haugsten, Ellen Margrethe
    Wiedlocha, Antoni
    CELLS, 2021, 10 (06)
  • [37] Fibroblast growth factor receptor (FGFR)-4, but not FGFR-3 is expressed in the pregnant ovary
    Puscheck, EE
    Patel, Y
    Rappolee, DA
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1997, 132 (1-2) : 169 - 176
  • [38] Fibroblast Growth Factor Receptor 4 (FGFR4) in Cushing Disease Outcome: Influence of Expression and of the G388R Functional Polymorphism.
    Brito, L. P.
    Lerario, A. M.
    Bronstein, M. D.
    Mendonca, B. B.
    Fragoso, M. C. B. V.
    ENDOCRINE REVIEWS, 2010, 31 (03)
  • [39] Fibroblast growth factor receptor 4 (FGFR4) expression as a prognostic indicator in high-grade serous ovarian carcinoma (HGSC): Signaling pathway, mechanism, and implication for therapeutic targeting
    Zaid, T. M.
    Thompson, M.
    Wong, K.
    Yeung, T.
    Yeung, Z.
    Gershenson, D. M.
    Birrer, M. J.
    Mok, S. C.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [40] Interaction between Fibroblast Growth Factor Receptor (FGFR) and Progesterone Receptor (PR) in experimental breast cancer.
    Cerliani, Juan
    Lamb, Caroline
    Lanari, Claudia
    CANCER RESEARCH, 2009, 69
12345